|Videos|June 19, 2021
Assessing IOL options for cataract patients
Author(s)OT Staff Reports
Alex Delaney-Gesing
Alex Delaney-Gesing
In recognition of Cataract Awareness Month, Fasika Woreta, MD, MPH, discusses IOL options for cataract patients.
Advertisement
Fasika Woreta, MD, MPH, of the Wilmer Eye Institute, Johns Hopkins University School of Medicine, discusses the determining factors and indicators to consider when treating cataract patients with IOLs.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Related Articles
- EyeCon 2025: Sun, sea, and a shared vision for the future of eye care
September 17th 2025
- STAAR Surgical files definitive proxy statement on pending merger with Alcon
September 16th 2025
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Idebenone accepted by FDA for priority review for Leber Hereditary Optic Neuropathy
2
Luxa Biotechnology announces clinical trial results for treatment of AMD
3
STAAR Surgical confirms expiration of “window shop” period in Alcon merger agreement
4
The European Commission grants marketing authorization for EYLUXVI
5